http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021511315-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2019-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021511315-A |
| titleOfInvention | Substituted pyrazolo [3,4-d] pyrimidine compounds as RET kinase inhibitors |
| abstract | Provided herein are Formula I: [Chemical 1] Compounds and their tautomers, as well as pharmaceutically acceptable salts and kinases, where R 1 and R 2 have the meanings given herein and these are RET. Kinase inhibitors are useful in the treatment and prevention of diseases that can be treated with RET kinase inhibitors, including diseases and disorders associated with RET. |
| priorityDate | 2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1695.